NCT01986296View on ClinicalTrials.gov

ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Medication-refractory Obsessive Compulsive Disorder (OCD)
Interventions
DEVICE

ExAblate Transcranial MRgFUS System

Treatment with the ExAblate Transcranial MRgFUS System.

Trial Locations (1)

120-752

Yonsei University Medical Center, Seoul

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01986296 - ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder | Biotech Hunter | Biotech Hunter